Healthcare -
Biotechnology - NASDAQ - US
$ 9.5
0.849 %
$ 968 M
Market Cap
-1.74
P/E
NTLA - COST OF REVENUE
Cost of Revenue NTLA - Intellia Therapeutics, Inc.
8.98 M
LAST VALUE
14.13%
2 YEAR CAGR
-36.81%
5 YEAR CAGR
0.00%
10 YEAR CAGR